# Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function

> **NCT00416702** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 32 (estimated)

## Conditions studied

- Hepatic Insufficiency

## Interventions

- **DRUG:** QAB149

## Key facts

- **NCT ID:** NCT00416702
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2008-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416702, "Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00416702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*